Ignite Creation Date:
2025-12-24 @ 9:14 PM
Ignite Modification Date:
2026-06-29 @ 11:21 AM
Study NCT ID:
NCT02086604
Status:
COMPLETED
Last Update Posted:
2022-02-17
First Post:
2014-03-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Brentuximab Vedotin and Lenalidomide for Relapsed or Refractory Diffuse Large B-cell Lymphoma
Sponsor:
Organization: